Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?
about
30 Years of the Mineralocorticoid Receptor: Mineralocorticoid receptor antagonists: 60 years of research and development.A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy.Revisiting RAAS blockade in CKD with newer potassium-binding drugs.Pharmacologic Management for Heart Failure and Emerging Therapies.Progress in the Management of Primary Aldosteronism.Diabetic nephropathy: newer therapeutic perspectives
P2860
Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Finerenone: a New Mineralocort ...... ortunity in Patients with CKD?
@en
type
label
Finerenone: a New Mineralocort ...... ortunity in Patients with CKD?
@en
prefLabel
Finerenone: a New Mineralocort ...... ortunity in Patients with CKD?
@en
P2093
P2860
P1476
Finerenone: a New Mineralocort ...... ortunity in Patients with CKD?
@en
P2093
Anna Bertram
Klaus Stahl
P2860
P2888
P356
10.1007/S11906-016-0649-2
P577
2016-04-01T00:00:00Z
P6179
1037058002